Literature DB >> 11421201

Neuropeptide FF: new molecular insights.

J M Zajac.   

Abstract

Mesh：

Substances：

Year:  2001        PMID： 11421201     DOI： 10.1016/s0165-6147(00)01610-2

Source DB:  PubMed          Journal:  Trends Pharmacol Sci        ISSN： 0165-6147            Impact factor:   14.819


× No keyword cloud information.
  4 in total

1.  GRK2 protein-mediated transphosphorylation contributes to loss of function of μ-opioid receptors induced by neuropeptide FF (NPFF2) receptors.

Authors:  Lionel Moulédous; Carine Froment; Stéphanie Dauvillier; Odile Burlet-Schiltz; Jean-Marie Zajac; Catherine Mollereau
Journal:  J Biol Chem       Date:  2012-02-28       Impact factor: 5.157

2.  RF9, a potent and selective neuropeptide FF receptor antagonist, prevents opioid-induced tolerance associated with hyperalgesia.

Authors:  Frédéric Simonin; Martine Schmitt; Jean-Paul Laulin; Emilie Laboureyras; Jack H Jhamandas; David MacTavish; Audrey Matifas; Catherine Mollereau; Patrick Laurent; Marc Parmentier; Brigitte L Kieffer; Jean-Jacques Bourguignon; Guy Simonnet
Journal:  Proc Natl Acad Sci U S A       Date:  2006-01-03       Impact factor: 11.205

3.  Identification and functional characterization of the phosphorylation sites of the neuropeptide FF2 receptor.

Authors:  Lauriane Bray; Carine Froment; Pierre Pardo; Cédric Candotto; Odile Burlet-Schiltz; Jean-Marie Zajac; Catherine Mollereau; Lionel Moulédous
Journal:  J Biol Chem       Date:  2014-10-17       Impact factor: 5.157

4.  Genes encoding neuropeptide receptors are epigenetic markers in patients with head and neck cancer: a site-specific analysis.

Authors:  Kiyoshi Misawa; Atsushi Imai; Daiki Mochizuki; Yuki Misawa; Shiori Endo; Seiji Hosokawa; Ryuji Ishikawa; Masato Mima; Kazuya Shinmura; Takeharu Kanazawa; Hiroyuki Mineta
Journal:  Oncotarget       Date:  2017-07-18
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.